HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behcet's syndrome
Authors:
- Sara PisantySPSara Pisanty
- Hilla KnoblerHKHilla Knobler
- Yaacov MatznerYMYaacov Matzner
- Michael GlickMGMichael Glick
- Noemi RonNRNoemi Ron
- Eliezer RosenmanEREliezer Rosenman
- Chaim BrautbarCBChaim Brautbar
- 1 October 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 83 (4) , 666-672
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1984
- An Inherited Abnormality of Neutrophil AdhesionNew England Journal of Medicine, 1980
- Behçet disease (Behçet syndrome)Seminars in Arthritis and Rheumatism, 1979
- Enhanced Chemotactic and Phagocytic Activities of Leukocytes in Psoriasis VulgarisJournal of Investigative Dermatology, 1978
- A Specific Inhibitor of Complement (C5)-Derived Chemotactic Activity in Serum from Patients with Systemic Lupus ErythematosusJournal of Clinical Investigation, 1978
- Microdroplet Testing for HLA-A, -B, -C, and -D Antigens: The Philip Levine Award LectureAmerican Journal of Clinical Pathology, 1978
- A Genetic Study of Behqet Disease in IsraelTissue Antigens, 1978
- Leucocyte movement and colchicine treatment in Behcet's diseaseThe Lancet, 1975
- HL-A5 AND BEHCET'S DISEASEThe Lancet, 1973
- LEUKOCYTE LOCOMOTION AND CHEMOTAXISJournal of Experimental Medicine, 1973